NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Monday that its first quarter revenues rose 25 percent year over year, thanks largely to a 62 percent increase in revenues from its diagnostics business.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.